Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1996 Oct;74(7):1063–1068. doi: 10.1038/bjc.1996.490

Nm23 expression in endometrial and cervical cancer: inverse correlation with lymph node involvement and myometrial invasion.

M Marone 1, G Scambia 1, G Ferrandina 1, C Giannitelli 1, P Benedetti-Panici 1, S Iacovella 1, A Leone 1, S Mancuso 1
PMCID: PMC2077129  PMID: 8855975

Abstract

The expression of nm23 has been shown to correlate in some solid tumours with their metastatic potential and to be associated with a favourable prognosis in human breast cancer and melanoma. In breast and ovarian cancer nm23 expression is also correlated with lymph node involvement. We analysed the expression of nm23-H1 and -H2 in normal endometrium and in endometrial and cervical cancer by both Northern and Western blotting. Cellular localisation of Nm23-H1 was visualised by immunohistochemistry mostly in the cytoplasm. Both isoforms of Nm23 were present in all the samples analysed, and a clear direct correlation between Nm23-H1 and -H2 levels was evident. Median nm23-H2 levels were higher than than -H1 levels in both tissues. Cervical cancer patients with lymph node involvement were shown to have significantly lower protein levels of Nm23 (P < 0.007 for H1 and P < 0.009 for H2), and a similar trend was also evident in endometrial cancer. Furthermore, the degree of myometrial invasion in endometrial cancer patients was also inversely correlated with Nm23-H1 levels of expression (P < 0.003). Nm23 level may therefore be taken into consideration as a new marker in the prognostic characterisation and in the treatment planning of uterine tumour patients.

Full text

PDF
1067

Images in this article

1065Figure 1
on p.1065
1065Figure 2
on p.1065
1066Figure 3
on p.1066

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ambros R. A., Vigna P. A., Figge J., Kallakury B. V., Mastrangelo A., Eastman A. Y., Malfetano J., Figge H. L., Ross J. S. Observations on tumor and metastatic suppressor gene status in endometrial carcinoma with particular emphasis on p53. Cancer. 1994 Mar 15;73(6):1686–1692. doi: 10.1002/1097-0142(19940315)73:6<1686::aid-cncr2820730622>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  2. Bevilacqua G., Sobel M. E., Liotta L. A., Steeg P. S. Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. Cancer Res. 1989 Sep 15;49(18):5185–5190. [PubMed] [Google Scholar]
  3. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  4. Flørenes V. A., Aamdal S., Myklebost O., Maelandsmo G. M., Bruland O. S., Fodstad O. Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progression. Cancer Res. 1992 Nov 1;52(21):6088–6091. [PubMed] [Google Scholar]
  5. Gilles A. M., Presecan E., Vonica A., Lascu I. Nucleoside diphosphate kinase from human erythrocytes. Structural characterization of the two polypeptide chains responsible for heterogeneity of the hexameric enzyme. J Biol Chem. 1991 May 15;266(14):8784–8789. [PubMed] [Google Scholar]
  6. Howlett A. R., Petersen O. W., Steeg P. S., Bissell M. J. A novel function for the nm23-H1 gene: overexpression in human breast carcinoma cells leads to the formation of basement membrane and growth arrest. J Natl Cancer Inst. 1994 Dec 21;86(24):1838–1844. doi: 10.1093/jnci/86.24.1838. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Jiang X. P., Liu K. D., Zhou X. D. [Cloning and sequencing of nm23-H3b, a new gene identified to nm23]. Zhonghua Yi Xue Za Zhi. 1994 Nov;74(11):670-2, 709. [PubMed] [Google Scholar]
  8. Knecht D. A., Dimond R. L. Visualization of antigenic proteins on Western blots. Anal Biochem. 1984 Jan;136(1):180–184. doi: 10.1016/0003-2697(84)90321-x. [DOI] [PubMed] [Google Scholar]
  9. Konishi N., Nakaoka S., Tsuzuki T., Matsumoto K., Kitahori Y., Hiasa Y., Urano T., Shiku H. Expression of nm23-H1 and nm23-H2 proteins in prostate carcinoma. Jpn J Cancer Res. 1993 Oct;84(10):1050–1054. doi: 10.1111/j.1349-7006.1993.tb02800.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Leone A., Flatow U., VanHoutte K., Steeg P. S. Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: effects on tumor metastatic potential, colonization and enzymatic activity. Oncogene. 1993 Sep;8(9):2325–2333. [PubMed] [Google Scholar]
  11. Leone A., Seeger R. C., Hong C. M., Hu Y. Y., Arboleda M. J., Brodeur G. M., Stram D., Slamon D. J., Steeg P. S. Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas. Oncogene. 1993 Apr;8(4):855–865. [PubMed] [Google Scholar]
  12. Liotta L. A., Steeg P. S. Clues to the function of Nm23 and Awd proteins in development, signal transduction, and tumor metastasis provided by studies of Dictyostelium discoideum. J Natl Cancer Inst. 1990 Jul 18;82(14):1170–1172. doi: 10.1093/jnci/82.14.1170. [DOI] [PubMed] [Google Scholar]
  13. Lombardi D., Sacchi A., D'Agostino G., Tibursi G. The association of the Nm23-M1 protein and beta-tubulin correlates with cell differentiation. Exp Cell Res. 1995 Apr;217(2):267–271. doi: 10.1006/excr.1995.1086. [DOI] [PubMed] [Google Scholar]
  14. MacDonald N. J., De la Rosa A., Benedict M. A., Freije J. M., Krutsch H., Steeg P. S. A serine phosphorylation of Nm23, and not its nucleoside diphosphate kinase activity, correlates with suppression of tumor metastatic potential. J Biol Chem. 1993 Dec 5;268(34):25780–25789. [PubMed] [Google Scholar]
  15. Mandai M., Konishi I., Koshiyama M., Mori T., Arao S., Tashiro H., Okamura H., Nomura H., Hiai H., Fukumoto M. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression. Cancer Res. 1994 Apr 1;54(7):1825–1830. [PubMed] [Google Scholar]
  16. Nakayama H., Yasui W., Yokozaki H., Tahara E. Reduced expression of nm23 is associated with metastasis of human gastric carcinomas. Jpn J Cancer Res. 1993 Feb;84(2):184–190. doi: 10.1111/j.1349-7006.1993.tb02853.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Nakayama T., Ohtsuru A., Nakao K., Shima M., Nakata K., Watanabe K., Ishii N., Kimura N., Nagataki S. Expression in human hepatocellular carcinoma of nucleoside diphosphate kinase, a homologue of the nm23 gene product. J Natl Cancer Inst. 1992 Sep 2;84(17):1349–1354. doi: 10.1093/jnci/84.17.1349. [DOI] [PubMed] [Google Scholar]
  18. Ohtsuki K., Ikeuchi T., Yokoyama M. Characterization of nucleoside-diphosphate kinase-associated guanine nucleotide-binding proteins from HeLa S3 cells. Biochim Biophys Acta. 1986 Jul 16;882(3):322–330. doi: 10.1016/0304-4165(86)90254-0. [DOI] [PubMed] [Google Scholar]
  19. Okabe-Kado J., Kasukabe T., Honma Y., Hayashi M., Henzel W. J., Hozumi M. Identity of a differentiation inhibiting factor for mouse myeloid leukemia cells with NM23/nucleoside diphosphate kinase. Biochem Biophys Res Commun. 1992 Feb 14;182(3):987–994. doi: 10.1016/0006-291x(92)91829-f. [DOI] [PubMed] [Google Scholar]
  20. Panici P. B., Scambia G., Baiocchi G., Greggi S., Ragusa G., Gallo A., Conte M., Battaglia F., Laurelli G., Rabitti C. Neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. Prognostic factors for response and survival. Cancer. 1991 Jan 15;67(2):372–379. doi: 10.1002/1097-0142(19910115)67:2<372::aid-cncr2820670210>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
  21. Postel E. H., Berberich S. J., Flint S. J., Ferrone C. A. Human c-myc transcription factor PuF identified as nm23-H2 nucleoside diphosphate kinase, a candidate suppressor of tumor metastasis. Science. 1993 Jul 23;261(5120):478–480. doi: 10.1126/science.8392752. [DOI] [PubMed] [Google Scholar]
  22. Postel E. H., Ferrone C. A. Nucleoside diphosphate kinase enzyme activity of NM23-H2/PuF is not required for its DNA binding and in vitro transcriptional functions. J Biol Chem. 1994 Mar 25;269(12):8627–8630. [PubMed] [Google Scholar]
  23. Scambia G., Catozzi L., Benedetti-Panici P., Ferrandina G., Battaglia F., Giovannini G., Distefano M., Pellizzola D., Piffanelli A., Mancuso S. Expression of ras p21 oncoprotein in normal and neoplastic human endometrium. Gynecol Oncol. 1993 Sep;50(3):339–346. doi: 10.1006/gyno.1993.1222. [DOI] [PubMed] [Google Scholar]
  24. Scambia G., Ferrandina G., Marone M., Benedetti Panici P., Giannitelli C., Piantelli M., Leone A., Mancuso S. nm23 in ovarian cancer: correlation with clinical outcome and other clinicopathologic and biochemical prognostic parameters. J Clin Oncol. 1996 Feb;14(2):334–342. doi: 10.1200/JCO.1996.14.2.334. [DOI] [PubMed] [Google Scholar]
  25. Stahl J. A., Leone A., Rosengard A. M., Porter L., King C. R., Steeg P. S. Identification of a second human nm23 gene, nm23-H2. Cancer Res. 1991 Jan 1;51(1):445–449. [PubMed] [Google Scholar]
  26. Steeg P. S., Bevilacqua G., Kopper L., Thorgeirsson U. P., Talmadge J. E., Liotta L. A., Sobel M. E. Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst. 1988 Apr 6;80(3):200–204. doi: 10.1093/jnci/80.3.200. [DOI] [PubMed] [Google Scholar]
  27. Tokunaga Y., Urano T., Furukawa K., Kondo H., Kanematsu T., Shiku H. Reduced expression of nm23-H1, but not of nm23-H2, is concordant with the frequency of lymph-node metastasis of human breast cancer. Int J Cancer. 1993 Aug 19;55(1):66–71. doi: 10.1002/ijc.2910550113. [DOI] [PubMed] [Google Scholar]
  28. Viel A., Dall'Agnese L., Canzonieri V., Sopracordevole F., Capozzi E., Carbone A., Visentin M. C., Boiocchi M. Suppressive role of the metastasis-related nm23-H1 gene in human ovarian carcinomas: association of high messenger RNA expression with lack of lymph node metastasis. Cancer Res. 1995 Jun 15;55(12):2645–2650. [PubMed] [Google Scholar]
  29. Walton G. M., Gill G. N. Nucleotide regulation of a eukaryotic protein synthesis initiation complex;. Biochim Biophys Acta. 1975 May 1;390(2):231–245. doi: 10.1016/0005-2787(75)90344-5. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES